Veracyte, Inc. (VCYT)
NASDAQ: VCYT · Real-Time Price · USD
43.96
+0.84 (1.94%)
Oct 19, 2026, 10:58 AM EDT - Market open

Veracyte Revenue

Veracyte had revenue of $150.32M in the quarter ending June 30, 2026, with 15.49% growth. This brings the company's total for the last twelve months to $561.90M, up 17.28% year-over-year. In the year 2025, Veracyte had annual revenue of $517.15M with 16.01% growth. That makes Veracyte the 10,582nd largest company in the world by revenue and 2,227th in the United States.

Revenue (ttm)
$561.90M
Revenue Growth
+17.28%
P/S Ratio
6.17
Revenue / Employee
$744,238
Employees
755
Market Cap
3.53B

Revenue Chart

Revenue by Geography

  • United States 496.60M 96.0%
  • International 20.55M 4.0%
Fiscal year ended Dec 31, 2025 See the full Veracyte breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025517.15M71.38M16.01%
Dec 31, 2024445.76M84.71M23.46%
Dec 31, 2023361.05M64.52M21.76%
Dec 31, 2022296.54M77.02M35.09%
Dec 31, 2021219.51M102.03M86.85%
Dec 31, 2020117.48M-2.89M-2.40%
Dec 31, 2019120.37M28.36M30.82%
Dec 31, 201892.01M20.06M27.87%
Dec 31, 201771.95M6.87M10.55%
Dec 31, 201665.09M15.58M31.48%
Dec 31, 201549.50M11.31M29.62%
Dec 31, 201438.19M16.31M74.51%
Dec 31, 201321.88M10.26M88.20%
Dec 31, 201211.63M8.98M339.62%
Dec 31, 20112.65M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
RadNet2.27B
Qiagen2.10B
Sotera Health Company1.22B
NeoGenomics766.30M
CareDx458.09M
GeneDx Holdings454.43M
BillionToOne397.41M
Adaptive Biotechnologies308.08M
Revenue Rankings